These two Kaplan-Meier plots compare Dutasteride (0.5 mg/day) to Placebo in a randomized, double-blind trial from 2012 of 187 men who have progressed to PSA Failure.
In the upper plot, Dutasteride increases the Doubling Time from, for example, 9 months to 18 months (factor of 2X).
In the lower plot, Dutasteride increases the Time to Disease Progression (intent to treat) from, for example, 9 months to 18 months (factor of 2X).
Dutasteride reduces DHT levels by more than 90%, and DHT is what "fuels" prostate cancer growth. Plus, it treats Male Pattern Baldness!
pubmed.ncbi.nlm.nih.gov/231...
Thanks to Kanzan for posting this article!